blue-fuse for bac and 4x44k oligo-microarrays software package (BlueGnome Limited)
Structured Review
Blue Fuse For Bac And 4x44k Oligo Microarrays Software Package, supplied by BlueGnome Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bac+microarray/cytochip+isca+4x44k+v1+0/pm34338393-52-7-13
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Clinical impact of copy number variation changes in bladder cancer samples. Article Snippet: Two independent platforms were used for the detection of genomic imbalances: i) Article Title: Clinical impact of copy number variation changes in bladder cancer samples Article Snippet: Two independent platforms were used for the detection of genomic imbalances: i) Article Title: Multiplex Proteomic Evaluation in Inborn Errors with Deregulated IgE Response. Article Snippet: Genomic Hybridization Microarray (Array–CGH) Analysis Based on the presence of multiple congenital anomalies and dysmorphisms, a comparative genomic hybridization microarray (Array–CGH) analysis using the Article Title: Multiplex Proteomic Evaluation in Inborn Errors with Deregulated IgE Response Article Snippet: Based on the presence of multiple congenital anomalies and dysmorphisms, a comparative genomic hybridization microarray (Array–CGH) analysis using the BAC Assay:Article Title: A 343 Italian cohort of patients analysed with array-comparative genomic hybridization: unsolved problems and genetic counselling difficulties. Article Snippet: Background The recent introduction of microarrays for genetic analyses has allowed higher etiological diagnostic rates in patient with intellectual disability (ID), autism spectrum disorders (ASD), epilepsy and multiple congenital anomalies (MCA), because of its resolution.. This approach still results of high complexity and some limitations have been reported.. In fact, it discloses several variants of unknown significance (VOUS) or incidental findings. Software:Article Title: A 343 Italian cohort of patients analysed with array-comparative genomic hybridization: unsolved problems and genetic counselling difficulties. Article Snippet: Background The recent introduction of microarrays for genetic analyses has allowed higher etiological diagnostic rates in patient with intellectual disability (ID), autism spectrum disorders (ASD), epilepsy and multiple congenital anomalies (MCA), because of its resolution.. This approach still results of high complexity and some limitations have been reported.. In fact, it discloses several variants of unknown significance (VOUS) or incidental findings. Microarray:Article Title: Improving risk-stratification of patients with chronic lymphocytic leukemia using multivariate patient similarity networks. Article Snippet: Background: Better risk-stratification of patients with chronic lymphocytic leukemia (CLL) and identification of subsets of ultra-high-risk (HR)-CLL patients are crucial in the contemporary era of an expanded therapeutic armamentarium for CLL.. Methods: A multivariate patient similarity network and clustering was applied to assess the prognostic values of routine genetic, laboratory, and clinical factors and to identify subsets of ultra-HR-CLL patients.. The study cohort consisted of 116 HR-CLL patients (F/M 36/80, median age 63 yrs) carrying del(11q), del(17p)/TP53 mutations and/or complex karyotype (CK) at the time of diagnosis. |
